↓ Skip to main content

BCMA-targeted immunotherapy for multiple myeloma

Overview of attention for article published in Journal of Hematology & Oncology, September 2020
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (91st percentile)
  • High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

news
3 news outlets
twitter
5 X users

Citations

dimensions_citation
113 Dimensions

Readers on

mendeley
177 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
BCMA-targeted immunotherapy for multiple myeloma
Published in
Journal of Hematology & Oncology, September 2020
DOI 10.1186/s13045-020-00962-7
Pubmed ID
Authors

Bo Yu, Tianbo Jiang, Delong Liu

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 177 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 177 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 24 14%
Student > Ph. D. Student 23 13%
Student > Bachelor 13 7%
Student > Master 10 6%
Other 9 5%
Other 12 7%
Unknown 86 49%
Readers by discipline Count As %
Medicine and Dentistry 25 14%
Biochemistry, Genetics and Molecular Biology 17 10%
Pharmacology, Toxicology and Pharmaceutical Science 10 6%
Immunology and Microbiology 9 5%
Agricultural and Biological Sciences 7 4%
Other 19 11%
Unknown 90 51%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 30. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 October 2022.
All research outputs
#1,260,933
of 24,654,957 outputs
Outputs from Journal of Hematology & Oncology
#63
of 1,265 outputs
Outputs of similar age
#34,628
of 413,350 outputs
Outputs of similar age from Journal of Hematology & Oncology
#6
of 35 outputs
Altmetric has tracked 24,654,957 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,265 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.5. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 413,350 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 35 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 85% of its contemporaries.